charges of fraud for off-label marketing of OP-1 , Stryker’s own bone-growth product. OP-1 was approved by the FDA for a very narrow use. But the feds say the company encouraged unapproved use by giving surgeons “recipies” for combining OP-1...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The “Tootsie Roll” Recipe: Biotech Managers Charged With Fraud
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account